SCHEMBL4428190

SCHEMBL4428190

Cc1cn([C@]2(Cl)O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)nc1N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.34
MTOR P42345 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 2/20 0.34
DNMT1 P26358 2/20 0.34
THRB P10828 1/20 0.34
MDM2 Q00987 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
POLB P06746 1/20 0.34
GMNN O75496 1/20 0.34
TP53 P04637 1/20 0.34
NFKB1 P19838 1/20 0.34
THPO P40225 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
BLM P54132 1/20 0.34
HBB P68871 1/20 0.34
PMP22 Q01453 1/20 0.34
PDE4D Q08499 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL234386 0.84 LMNA (0.34) LMNAMTORSMN1; SMN2ALDH1A1DNMT1
SCHEMBL1684840 0.84 DNMT1 (0.34) LMNAMTORSMN1; SMN2ALDH1A1DNMT1
SCHEMBL17748439 0.82 LMNA (0.33) LMNAMTORSMN1; SMN2ALDH1A1DNMT1
SCHEMBL6241745 0.81 LMNA (0.35) LMNAMTORSMN1; SMN2ALDH1A1DNMT1
SCHEMBL20500065 0.81 LMNA (0.33) LMNAMTORSMN1; SMN2ALDH1A1DNMT1
SCHEMBL27908324 0.81 PDE4D (0.33) LMNAMTORSMN1; SMN2ALDH1A1DNMT1
SCHEMBL27090390 0.80 LMNA (0.34) LMNAMTORSMN1; SMN2ALDH1A1DNMT1
SCHEMBL4414286 0.78 LMNA (0.51) LMNAMTORSMN1; SMN2ALDH1A1DNMT1
SCHEMBL18007504 0.78 ADORA2A (0.31) LMNAMTORSMN1; SMN2ALDH1A1DNMT1
SCHEMBL6914466 0.78 LMNA (0.31) LMNAMTORSMN1; SMN2ALDH1A1DNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1804821-A4 HCV NS3-NS4A PROTEASE INHIBITION VERTEX PHARMA (US) 2009-07-15 EP disclosed
EP-1804821-A2 HCV NS3-NS4A PROTEASE INHIBITION Vertex Pharmaceuticals, Inc. (US) 2007-07-11 EP disclosed
WO-2006039488-A2 HCV NS3-NS4A PROTEASE INHIBITION VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-04-13 WO disclosed